BTS guidelines for the management of malignant pleural effusions.
作者信息
Antunes G, Neville E, Duffy J, Ali N
机构信息
Department of Respiratory Medicine, James Cook University Hospital, Middlesborough TS4 3BW, UK.
出版信息
Thorax. 2003 May;58 Suppl 2(Suppl 2):ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29.
Abstract
摘要
相似文献
1
BTS guidelines for the management of malignant pleural effusions.
Thorax. 2003 May;58 Suppl 2(Suppl 2):ii29-38. doi: 10.1136/thorax.58.suppl_2.ii29.
2
Management of malignant pleural effusions.
Adv Ther. 2010 Jun;27(6):334-47. doi: 10.1007/S12325-010-0031-8. Epub 2010 Jun 10.
3
Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010.
Thorax. 2010 Aug;65 Suppl 2:ii32-40. doi: 10.1136/thx.2010.136994.
4
Emerging paradigms in the management of malignant pleural effusions.
Respir Med. 2008 Jul;102(7):939-48. doi: 10.1016/j.rmed.2008.01.022. Epub 2008 Mar 19.
5
[Management of pleura effusions].
MMW Fortschr Med. 2011 Nov 3;153(44):39-41. doi: 10.1007/BF03369030.
6
Treatment options for malignant pleural effusion.
Curr Opin Pulm Med. 2009 Jul;15(4):380-7. doi: 10.1097/MCP.0b013e32832c6a8a.
7
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial.
JAMA. 2015;314(24):2641-53. doi: 10.1001/jama.2015.16840.
8
Multidisciplinary management of malignant pleural effusion.
J Surg Oncol. 2012 Jun 1;105(7):731-8. doi: 10.1002/jso.22100. Epub 2011 Sep 29.
9
Management of Malignant Pleural Effusions-What Is New.
Semin Respir Crit Care Med. 2019 Jun;40(3):323-339. doi: 10.1055/s-0039-1698285. Epub 2019 Sep 16.
10
Management of malignant pleural effusion.
Nurs Clin North Am. 2001 Dec;36(4):665-83, vi.
引用本文的文献
1
The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions.
Cancers (Basel). 2025 Jun 25;17(13):2143. doi: 10.3390/cancers17132143.
2
Unravelling the Efficacy of Internal Quilting Sutures vs Doxycycline Instillations in Preventing Seroma Formation After Gynecomastia Surgery.
Aesthet Surg J Open Forum. 2024 Sep 10;7:ojae078. doi: 10.1093/asjof/ojae078. eCollection 2025.
3
First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?
Invest New Drugs. 2024 Apr;42(2):196-206. doi: 10.1007/s10637-024-01424-4. Epub 2024 Feb 22.
4
Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review.
Pharmaceutics. 2023 Jun 6;15(6):1664. doi: 10.3390/pharmaceutics15061664.
5
Retrospective review comparing intrapleural fibrinolytic therapy (alteplase) and surgical intervention in complex pleural effusion.
BMC Pulm Med. 2022 Nov 23;22(1):439. doi: 10.1186/s12890-022-02239-w.
6
Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study.
Front Immunol. 2022 Oct 5;13:1002938. doi: 10.3389/fimmu.2022.1002938. eCollection 2022.
7
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study.
Respirology. 2022 May;27(5):350-356. doi: 10.1111/resp.14232. Epub 2022 Feb 17.
8
Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on F-FDG PET/CT.
EJNMMI Res. 2021 Oct 15;11(1):108. doi: 10.1186/s13550-021-00850-2.
9
Success of Using Iodopovidone as a Sclerosing Agent for Chemical Pleurodesis in a Tertiary Care Center: A Descriptive Cross-Sectional Study.
JNMA J Nepal Med Assoc. 2021 Jan 31;59(233):69-73. doi: 10.31729/jnma.6033.
10
Pleurodesis with povidone iodine in patients with malignant pleural effusion in a tertiary center in Nigeria.
Pan Afr Med J. 2021 Feb 15;38:169. doi: 10.11604/pamj.2021.38.169.22405. eCollection 2021.
本文引用的文献
1
THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.
J Clin Invest. 1949 Jan;28(1):173-90. doi: 10.1172/JCI102046.
2
Talc preparations used for pleurodesis vary markedly from one preparation to another.
Chest. 2001 Jun;119(6):1901-5. doi: 10.1378/chest.119.6.1901.
3
Thoracoscopy talc poudrage : a 15-year experience.
Chest. 2001 Mar;119(3):801-6. doi: 10.1378/chest.119.3.801.
4
Pathogenesis of malignant pleural effusions and talc pleurodesis.
Pneumologie. 1999 Oct;53(10):493-8. doi: 10.1055/s-1999-9040.
5
A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions.
Cancer. 1999 Nov 15;86(10):1992-9.
6
Using urokinase to treat malignant pleural effusions.
AJR Am J Roentgenol. 1999 Sep;173(3):781-3. doi: 10.2214/ajr.173.3.10470923.
7
Intrapleural streptokinase in the management of malignant multiloculated pleural effusions.
Chest. 1999 Mar;115(3):729-33. doi: 10.1378/chest.115.3.729.
8
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Cancer. 1999 Jan 1;85(1):178-87.
9
Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.
Radiology. 1999 Jan;210(1):277-81. doi: 10.1148/radiology.210.1.r99dc04277.
10
Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study.
Respir Med. 1998 Mar;92(3):593-6. doi: 10.1016/s0954-6111(98)90315-8.
Zotero 插件